Parametrica Management LTD Cure Vac N.V. Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$13.18 - $19.41 $178,101 - $262,287	13,513 New	13,513 $184,000
Q2 2021 Aug 13, 2021	SELL	$56.91 - $127.53 $2.54 Million - $5.7 Million	-44,695 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$79.79 - $126.29 $507,863 - $803,835	6,365 Added 16.61%	44,695 $3.97 Million
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $1.79 Million - $5.22 Million	38,330 New	38,330 $3.11 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $514M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.